A-Level Capital Overview
- Investor Type
-
Venture Capital
- Status
-
Active
- Professionals
-
30
- Investments
-
58
- Portfolio
-
30
- Exits
-
26
A-Level Capital General Information
Company Description
Founded in 2015, A-Level Capital is a venture capital firm based in Baltimore, Maryland. The firm seeks to invest in Johns Hopkins University's start-up companies. The firm focuses on the medical, technology, and biotechnology sectors.
Business Details
Website
www.alevelcapital.comYear Founded
Investor Status
Primary Investor Type
Corporate Office
- 3400 North Charles Street
- Baltimore, MD 21218
- United States
A-Level Capital Investments (58)
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Company Stage | Lead Partner |
|---|---|---|---|---|---|---|
| Cofertility | 18-Apr-2025 | Early Stage VC | Clinics/Outpatient Services | Generating Revenue | ||
| Cerbrec | 04-Feb-2025 | Business/Productivity Software | Generating Revenue | |||
| Ashvattha Therapeutics | 13-Jan-2025 | Drug Discovery | Clinical Trials - Phase 2 | |||
| Dash Bio | 08-Oct-2024 | Discovery Tools (Healthcare) | Generating Revenue | |||
| Currence | 28-Aug-2024 | Media and Information Services (B2B) | Generating Revenue | |||
| Greenboard | 08-May-2024 | Financial Software | Generating Revenue | |||
| LoopGenius | 05-Apr-2024 | Business/Productivity Software | Generating Revenue | |||
| Glyphic Biotechnologies | 23-Feb-2024 | Biotechnology | Generating Revenue | |||
| Leap (San Francisco) | 10-Jan-2024 | Seed Round | Business/Productivity Software | Generating Revenue | ||
| Refresh (New York) | 31-Dec-2023 | Seed Round | Business/Productivity Software | Generating Revenue |
A-Level Capital Exits (26)
| Company Name | Exit Date | Exit Type | Exit Size |
|---|---|---|---|
| Proscia | 04-Nov-2026 | Merger/Acquisition | |
| Ground Control | 26-Jun-2026 | ||
| Helium Health | 01-Jun-2026 | ||
| Drift (Business/Productivity Software) | 12-Mar-2026 | ||
| Finley (Financial Software) | 25-Feb-2026 | ||
| InSilico Medicine Cayman | 30-Dec-2025 | ||
| Glidian | 17-Mar-2025 | ||
| Sherlock Biosciences | 19-Dec-2024 | ||
| Life House | 18-Dec-2024 | Merger/Acquisition | |
| Stage (Business or Productivity Software) | 01-Feb-2024 | Out of Business |
A-Level Capital Investments by Industry, Year, and Region
A-Level Capital Co-Investors (147)
| Name | With | Exits | Lead Partner | Series | Industry |
|---|---|---|---|---|---|
| Gaingels | 5 |
|
|
||
| 10X Capital |
|
|
|||
| Singularity Capital |
|
|
|||
| General Catalyst |
|
|
|||
| Valor Equity Partners |
|
|
A-Level Capital FAQs
-
What is A-Level Capital?
Founded in 2015, A-Level Capital is a venture capital firm based in Baltimore, Maryland.
-
When was A-Level Capital founded?
A-Level Capital was founded in 2015.
-
Where is A-Level Capital headquartered?
A-Level Capital is headquartered in Baltimore, MD.
-
What is A-Level Capital's total asset value?
A-Level Capital has around in total assets under management.
-
How many investments has A-Level Capital made?
A-Level Capital has made 58 investments.
-
What has A-Level Capital invested in?
A-Level Capital has made numerous investments in companies like Cofertility, Cerbrec, and Ashvattha Therapeutics within the Clinics/Outpatient Services, Business/Productivity Software, and Drug Discovery industries.
-
What has A-Level Capital invested in recently?
A-Level Capital's latest investment was on 18-Apr-2025 in Cofertility, a company within the Clinics/Outpatient Services industry.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process